CYCLOPHOSPHAMIDE (CYTOXAN)
Showing 1 - 25 of 2,453
Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)
Completed
- Metastatic Melanoma
- Aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 21, 2022
GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose
Terminated
- Graft Versus Host Disease
- Cyclophosphamide and Sirolimus
- +3 more
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Feb 4, 2022
Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,
Recruiting
- Lymphoproliferative Disorders
- +4 more
- Busulfan test dose
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)
Not yet recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023
Lymphoma, Large B-Cell, Diffuse Trial (Cyclophosphamide, TLI, Fludarabine)
Not yet recruiting
- Lymphoma, Large B-Cell, Diffuse
- Cyclophosphamide
- +2 more
- (no location specified)
Aug 18, 2023
Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)
Recruiting
- Graft Vs Host Disease
- Cyclophosphamide
- +2 more
-
New York, New YorkNYU Langone Health
Nov 10, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Cyclophosphamide
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 20, 2023
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
Anemia, Sickle Cell Trial in New York (Siplizumab, Exchange Transfusion, Total Body Irradiation)
Recruiting
- Anemia, Sickle Cell
- Siplizumab
- +7 more
-
New York, New YorkColumbia University Irving Medical Center
Oct 9, 2023
Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia
Completed
- Acute Lymphoblastic Leukemia
- Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
- Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 26, 2022
Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)
Not yet recruiting
- Stem Cell Transplantation
- Fludarabine
- +9 more
-
Houston, TexasM D Anderson Cancer Center
May 4, 2022
Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)
Recruiting
- Neuroblastoma
- Pediatric Cancer
- Cyclophosphamide
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 11, 2023
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)
Recruiting
- Refractory Solid Tumor
- +4 more
- Atezolizumab
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 4, 2022
Multiple Myeloma Trial in Little Rock (myPRS, Induction 1 - MEL-10+CFZ-TD-PACE, First Transplant - MEL-80+CFZ-TD-PACE + PBSC
Terminated
- Multiple Myeloma
- myPRS
- +6 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
May 28, 2021
GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)
Active, not recruiting
- Graft Versus Host Disease
- Hematopoietic/Lymphoid Cancer
- fludarabine phosphate
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Lymphoma Trial in Houston (2CdA, Cyclophosphamide, Rituximab)
Completed
- Lymphoma
- 2CdA
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 3, 2022
Triple Negative Breast Cancer Trial in United States (Pembrolizumab, Cyclophosphamide)
Active, not recruiting
- Triple Negative Breast Cancer
-
Washington, District of Columbia
- +4 more
Nov 8, 2022
Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine
Not yet recruiting
- Multiple Myeloma
- Smoldering Multiple Myeloma
- Ciltacabtagene Autoleucel
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 2, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- Epacadostat
- +4 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023
Platinum-resistant Epithelial Ovarian Cancer Trial in Ocala, Mineola (Maveropepimut-S, Cyclophosphamide 50mg)
Recruiting
- Platinum-resistant Epithelial Ovarian Cancer
- Maveropepimut-S
- Cyclophosphamide 50mg
-
Ocala, Florida
- +1 more
Jul 20, 2022
Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)
Active, not recruiting
- Sickle Cell Anemia
- PBSC Transplant
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022